Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. New Strategies in Myelodysplastic Syndromes: Application of molecular diagnostics to clinical practice.

    ... complete compendium of recurrently mutated genes in myelodysplastic syndromes (MDS) has been defined, and the application of massively parallel ...

    Research Article last updated 02/04/2013 - 2:55pm.

  2. The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail

    ... are effective and approved therapies for patients with myelodysplastic syndromes (MDS), many patients do not benefit from treatment, and nearly ...

    Research Article last updated 03/22/2017 - 9:28am.

  3. Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia

    ... Patients with high risk myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) are commonly ...

    Research Article last updated 05/22/2017 - 11:42am.

  4. The value of survival gains in myelodysplastic syndromes.

    ... to the introduction of 3 novel therapies for myelodysplastic syndromes (MDS). STUDY DESIGN: Retrospective study of patients ...

    Research Article last updated 02/21/2017 - 11:36am.

  5. Professionals

    ... paroxysmal nocturnal hemoglobinuria (PNH), myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML). The program will bring ...

    Page last updated 02/13/2018 - 11:49am.

  6. Stem and progenitor cell alterations in myelodysplastic syndromes

    ... Recent studies have demonstrated that myelodysplastic syndromes (MDS) arise from a small population of disease initiating ...

    Research Article last updated 02/21/2017 - 10:17am.

  7. Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis

    ... binding protein 1 (SETBP1) mutations in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or chronic ...

    Research Article last updated 02/21/2017 - 10:33am.

  8. Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes

    ... Myelodysplastic syndromes are a heterogeneous group of clonal bone marrow hematopoietic ...

    Research Article last updated 09/24/2014 - 10:41am.

  9. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity

    ... of inherited bone marrow failure and inherited myelodysplastic syndromes is essential to guide clinical management. Distinguishing ...

    Research Article last updated 10/02/2014 - 10:20am.

  10. Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy

    ... is a key survival prognostic factor in lower-risk myelodysplastic syndromes (MDS). Lenalidomide (LEN) can correct anemia in 25% of ...

    Research Article last updated 02/21/2017 - 9:43am.